Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 14
Addenda to Table 1.....

Biotech Fools will want to apply their own due diligence to the evaluation of any of these companies. In particular, the question of whether or not a company has the resources to complete clinical trials and await FDA approval should be addressed. Another important factor will be the number and quality of clinical trials in Ph II, particularly if those trials are for cancer targets with this or other drug candidates. The more successful drugs a company has in that area of therapeutics, the better chance it has of building a marketing franchise with the oncology community.

Comapany 10-Ks, news releases, and published clinical papers are the primary sources of information. Here are the earlier Seminar Grads posts summarizing clinical results at the time of post for each disease state to help you get started;

Breast http://boards.fool.com/Message.asp?mid=13868935
Prostate http://boards.fool.com/Message.asp?mid=13882636
Lung http://boards.fool.com/Message.asp?mid=14783560
Colorectal http://boards.fool.com/Message.asp?mid=14110314
Lymphoma http://boards.fool.com/Message.asp?mid=14615390
Bladder http://boards.fool.com/Message.asp?mid=14523968
Melanoma http://boards.fool.com/Message.asp?mid=13903396

To find the incidence and mortality rate for any cancerous disease, go to SEER at http://seer.cancer.gov/Publications/CSR1973_1997/overview/overview24.pdf

A particularly informative site for descriptions of current therapy and status of current clinical approaches is NCI at http://cancernet.nci.nih.gov/

The classification of companies and projects is a judgment call. Your judgment, in the final analysis, is the one that counts.

The purpose of these posts that involve Table 1 is to give Biotechers a glance at the whole playing field of advanced anticancer clinical trials so that you may see where your favorite companies and drug candidates fit in. (Note that--though we've left out Big Pharma chemotherapy candidates--if the drug is actually a true biotech offering licensed or taken over by Big Pharma, we've tried to include it.) Once you've come to your conclusions, we'd like your proposals for creating a Ph III anticancer portfolio. Please propose your candidates and tell us your reasons....we'll eventually go with the ten that seem the most convincing overall. If there is a good reason to go with twenty, we'll break it into two ports. And if you think we've reported something inaccurately, or incorrectly omitted a company or drug candidate, please let us know. We'll do our best to correct our mistakes and misjudgments.

Waiting to hear from you....THE "SEMINAR" ANTICANCER TEAM (Barb, Cliff, Renee, & Sheila)

Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.